THE ROLE OF OVARIAN SUPPRESSION IN THE TREATMENT OF EARLY-STAGE HORMONE-SENSITIVE BREAST CANCER by I. A. Koroleva, M. V. Kopp

Get full text

POSSIBILITIES OF OVARIAL SUPPRESSION IN HORMONE-DEPENDENT MAMMARY GLAND CANCER by I. A. KOROLEVA, M. V. KOPP

Get full text

Fulvestrant in the treatment of luminal metastatic breast cancer: the balance of effectiveness and safety by I. A. Koroleva, M. V. Kopp

Get full text

CHEMOTHERAPY REGIMEN AC (DOXORUBICIN AND CYCLOPHOSPHAMIDE) IN BREAST CANCER – PREVENTION OF NAUSEA AND VOMITING by I. A. Koroleva, M. V. Kopp, E. M. Lipaeva

Get full text

Evaluation of the effectiveness of aprepitant for prevention of nausea and vomiting in patients with breast cancer by I. A. Koroleva, M. V. Kopp, A. M. Koroleva

Get full text

Bioequivalence assessment of BCD-022 (trastuzumab, manufactured by JSC BIOCAD, Russia) as compared with Herceptin® (F.Hoffmann-La Roche Ltd., Switzerland), used in combination with... by E O Ignatova, O N Burdaeva, M V Kopp, B N Kotiv, D P Udovitsa, D L Stroiakovskii, S M Alekseev, L P Sheveleva, A V Khorinko, Iu S Shapovalova, V M Moiseenko, R A Ivanov

Get full text